Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 18/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31408295 | 1.00 | PTGES (0.41) | PTGESSMN1; SMN2LOXL2 | |
| SCHEMBL31408503 | 1.00 | PTGES (0.41) | PTGESSMN1; SMN2LOXL2 | |
| SCHEMBL31408318 | 0.93 | PTGES (0.40) | PTGESSMN1; SMN2 | |
| SCHEMBL31408285 | 0.93 | PTGES (0.40) | PTGESSMN1; SMN2 | |
| SCHEMBL31408495 | 0.92 | PTGES (0.41) | PTGESSMN1; SMN2 | |
| SCHEMBL31408588 | 0.92 | PTGES (0.41) | PTGESSMN1; SMN2 | |
| SCHEMBL31408418 | 0.92 | PTGES (0.41) | PTGESSMN1; SMN2 | |
| SCHEMBL31408451 | 0.91 | PTGES (0.38) | PTGESSMN1; SMN2LOXL2 | |
| SCHEMBL31408411 | 0.91 | PTGES (0.38) | PTGESSMN1; SMN2LOXL2 | |
| SCHEMBL31408573 | 0.91 | PTGES (0.38) | PTGESSMN1; SMN2LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025049604-A1 | INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF | MAZE THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |